<aside> 🧬 “Biology is the next big thing. If I were young today, I would do biology” - Eric Schmidt.
</aside>
<aside> 👋 Orakl Oncology leverages tumour avatars that combine best-in-class biology with high-quality clinical and molecular data at scale. Our techbio platform partners with oncology players to identify relevant targets and deliver better drugs, faster.
</aside>
The drug development pipeline is under tension
Patient-derived organoids and pharmaceutical research
The science behind the project. Here are some of the works that have most impacted Orakl Oncology.
Feel free to drop any questions at: [email protected]. If you’re looking for any specific information you can write to us at:
<aside> 🤖 Fanny, co-founder, CEO & CSO
</aside>
<aside> ✉️ [email protected]
</aside>
<aside> 🤖 Diane-Laure, co-founder, COO
</aside>
<aside> ✉️ [email protected]
</aside>
<aside> 🤖 Gustave, co-founder, CTO
</aside>
<aside> ✉️ [email protected]
</aside>
<aside> 🏠 Orakl Oncology SAS, Bâtiment de Recherche de la Faculté de Médecine Paris-Saclay
63 rue Gabriel Péri
94276 Le Kremlin-Bicêtre
</aside>
<aside> 🌐 orakl-oncology.com
</aside>